Stefania Zappata
The Catholic University of America
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stefania Zappata.
The Lancet | 1995
Christina Brahe; Stefania Zappata; Giovanni Neri; Serenella Servidei; Enzo Ricci; P. Tonali
Molecular diagnosis of childhood proximal spinal muscular atrophy has been enhanced by the discovery of the survival motor neuron (SMN) gene, which is absent or truncated in 98.6% of patients. To determine whether deletion analysis of the SMN gene may also be diagnostic for adult-onset disease, we studied six patients and found deletions in all. This finding will facilitate the diagnosis of adult-onset spinal muscular atrophy, and provides evidence for genetic homogeneity between the clinically diverse adult and childhood forms of the disease.
European Journal of Human Genetics | 1999
Anna Letizia Patrizi; Francesco Danilo Tiziano; Stefania Zappata; Maria Alice Donati; Giovanni Neri; Christina Brahe
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by the homozygous absence of the telomeric copy of the survival motor neuron (SMNt) gene, due to deletion, gene conversion or point mutation. SMNt and its homologous centromeric copy (SMNc) encode the SMN protein, which is diffusely present in the cytoplasm and in dot-like structures, called gems, in the nucleus. We have studied the SMN protein in different cell cultures, including fibroblasts, amniocytes and CVS cells from SMA individuals and controls. By immunofluorescence analysis we found a marked reduction in the number of gems in fibroblasts, amniocytes and chorionic villus cells of all SMA patients and foetuses, independent of the type of the genetic defect. We also show that immunolocalisation of the SMN protein may be a useful tool for the characterisation of particular patients of uncertain molecular diagnosis.
Human Genetics | 1994
Cristina Beate Brahe; Velona; G Vandersteege; Stefania Zappata; Ay Vandeveen; Jan Osinga; C. Tops; Riccardo Fodde; Pm Khan; Chcm Buys; G Neri
The locus responsible for the childhood-onset proximal spinal muscular atrophies (SMA) has recently been mapped to an area of 2–3 Mb in the region q12–13.3 of chromosome 5. We have used a series of radiation hybrids (RHs) containing distinct parts of the SMA region as defined by reference markers. A cosmid library was constructed from one RH. Thirteen clones were isolated and five of these were mapped within the SMA region. Both RH mapping and fluorescence in situ hybridization analysis showed that two clones map in the region between loci D5S125 and D5S351. One of the cosmids contains expressed sequences. Polymorphic dinucleotide repeats were identified in both clones and used for segregation analysis of key recombinant SMA families. One recombination between the SMA locus and the new marker 9Ic (D5S685) indicates that 9Ic is probably the closest distal marker. The absence of recombination between the SMA locus and marker Fc (D5S684) suggests that Fc is located close to the disease gene. These new loci should refine linkage analysis in SMA family studies and may facilitate the isolation of the disease gene.
Human Genetics | 1996
Stefania Zappata; Francesco Danilo Tiziano; Giovanni Neri; Cristina Beate Brahe
Recently, a gene determining spinal muscular atrophy (SMA), termed survival motor neuron (SMN) gene, has been isolated from the 5g13 region. This gene has been found to be deleted in most patients with childhood-onset SMA. We have studied the SMN gene in a clinically heterogeneous family, including one patient affected by infantile chronic SMA and three subjects with mild adult-onset muscle weakness. Deletions in the SMN gene were detected in all of these patients, indicating that the childhood and adult SMAs are genetically homogeneous in this family. Genotyping of the family members established that the three mildly affected individuals were homozygous for the same haplotype from the SMA region, whereas the more severely affected patient was heterozygous with one different haplotype.
American Journal of Medical Genetics | 1997
Angelo Serra; Renato Bova; Grazia Bellanova; Antonino Chindemi; Stefania Zappata; Christina Brahe
We report on a case with a partial monosomy for the regions 9p23 --> pter and 13p11 --> pter as a result of a de novo translocation (9p23;13p11). The patient, a 16-year-old girl, has mental deficiency, obesity, and minor anomalies, including trigonocephaly, hypertelorism and a short, broad neck. Cytogenetic and microsatellite marker analysis allowed us to assign the breakpoint to the chromosomal region 9p23, flanked by the markers D9S144 and D9S157. In an attempt to establish a phenotype-genotype correlation, the clinical manifestations present in our patient are compared to those with partial 9p monosomy and breakpoint in p23, referred to in the literature.
American Journal of Medical Genetics | 1996
Gianfranco Sebastio; Lucia Perone; Vito Guzzetta; Lucia Sebastio; Laura Vicari; Roberto Della Casa; Fiorella Gurrieri; Stefania Zappata; M. Grazia Pomponi; Attilio Mazzei; Giovanni Neri; Generoso Andria; Christina Brahe
We report on an aneuploidy syndrome due to the unbalanced segregation of a familial translocation (4;21)(p16.3;q22.1) causing a partial 4p monosomy and a partial 21q trisomy. The three affected children presented with severe failure to thrive, short stature, microcephaly, profound hypotonia, and mental retardation. The face, very similar in the three children, is characterized by frontal bossing, upslanting of the palpebral fissures, short nose, and deep set ears, giving the overall appearance of the Down syndrome. The molecular study has defined the aneuploid segment on both 4p and 21q. Most of the Down syndrome critical region was found to the trisomic, while only part of the candidate Wolf-Hirschhorn syndrome critical region was deleted, suggesting that this region is not critical for the major malformations characteristic for WHS.
Human Genetics | 1994
Stefania Zappata; Michael B. Petersen; Ulrich König; Jillian Blaschak; Arvinda Chakravarti; Flora Tassone; Angelo Serra; Christina Brahe
We have identified a polymorphic compound dinucleotide repeat sequence in intron 1 of the β-amyloid precursor protein (APP) gene on chromosome 21. Using polymerase chain reaction (PCR) amplification of the locus, designated APPivsl, we detected 13 alleles in the CEPH family members (heterozygosity = 0.69). Lod score analysis showed complete linkage of the marker to the loci D21S210 and D21221.
Human Molecular Genetics | 1996
Christina Brahe; Olivier Clermont; Stefania Zappata; Francesco Danilo Tiziano; Judith Melki; Giovanni Neri
American Journal of Human Genetics | 1996
G Vandersteege; Pm Grootscholten; Jan-Hein Cobben; Stefania Zappata; H Scheffer; Jt Dendunnen; Gjb Vanommen; Cristina Beate Brahe; Chcm Buys
Human Molecular Genetics | 1999
Tiziana Vitali; Vittorio Sossi; Francesco Danilo Tiziano; Stefania Zappata; Anna Giuli; Maria Paravatou-Petsotas; Giovanni Neri; Christina Brahe